HIGHLANDS PRACTICE — All Prescriptions & Medications — Page 12
Practice Code: F85035 | LONDON, N21 1UJ
Showing results 551-600 of 648
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Bezafibrate | 16 | 457 | £111 | -70.3% ▼ |
| Glycopyrronium/formoterol | 16 | 16 | £494 | -36.8% ▼ |
| Lofepramine hydrochloride | 16 | 749 | £320 | -46.5% ▼ |
| Zonisamide | 16 | 1,624 | £948 | -63.3% ▼ |
| Nicotine | 16 | 970 | £729 | -71.7% ▼ |
| Methylprednisolone acetate | 16 | 16 | £59 | -86.1% ▼ |
| Pyridostigmine bromide | 16 | 3,600 | £273 | -6.5% ▼ |
| Other sunscreening preparations | 16 | 2,640 | £211 | +104.2% ▲ |
| Paliperidone | 15 | 16 | £4.8K | -1.4% vs avg |
| Flupentixol hydrochloride | 15 | 1,080 | £72 | -54.2% ▼ |
| Tibolone | 15 | 476 | £45 | -51.0% ▼ |
| Riboflavin | 15 | 3,372 | £4.2K | +62.2% ▲ |
| Powder amino acid formula (0913107) | 15 | 50.4K | £2.9K | -54.6% ▼ |
| Acetazolamide | 15 | 1,456 | £55 | -30.8% ▼ |
| Hyetellose | 15 | 800 | £355 | +86.3% ▲ |
| Lidocaine | 15 | 870 | £95 | +217.0% ▲ |
| Diclofenac sodium | 15 | 1,050 | £764 | -37.4% ▼ |
| 15 | 920 | £280 | -22.4% ▼ | |
| 15 | 1,671 | £133 | -85.2% ▼ | |
| 15 | 570 | £1.4K | -1.5% vs avg | |
| Sodium picosulfate | 14 | 1,600 | £147 | -61.4% ▼ |
| Cilostazol | 14 | 392 | £236 | +0.9% vs avg |
| Dabigatran etexilate | 14 | 1,512 | £1.2K | -73.0% ▼ |
| Omega-3-acid ethyl esters | 14 | 3,960 | £1.9K | -33.8% ▼ |
| Nefopam hydrochloride | 14 | 784 | £35 | -87.6% ▼ |
| Bupropion hydrochloride | 14 | 840 | £556 | +29.5% ▲ |
| Metformin hydrochloride/vildagliptin | 14 | 840 | £475 | -14.3% ▼ |
| Oestrogens conjugated with progestogen | 14 | 938 | £363 | +96.5% ▲ |
| Sodium chloride | 14 | 812 | £75 | -40.8% ▼ |
| Powder 1 - 2.2 kcal/ml soup (0913011) | 14 | 1,232 | £1.0K | +82.3% ▲ |
| Leflunomide | 14 | 570 | £37 | -63.0% ▼ |
| Hydrogen peroxide | 14 | 4,200 | £39 | +299.5% ▲ |
| Salicylic acid | 14 | 194 | £87 | +10.7% ▲ |
| 14 | 499 | £2.5K | +30.5% ▲ | |
| 14 | 420 | £57 | -47.9% ▼ | |
| 14 | 70 | £215 | +70.6% ▲ | |
| 14 | 760 | £94 | +6.1% ▲ | |
| 14 | 175 | £826 | +103.9% ▲ | |
| Co-tenidone (Atenolol/chlortalidone) | 13 | 840 | £111 | -37.7% ▼ |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 13 | 728 | £419 | -17.8% ▼ |
| Valproic acid | 13 | 510 | £92 | -85.1% ▼ |
| Hyoscine hydrobromide | 13 | 600 | £98 | -61.9% ▼ |
| Oxycodone hydrochloride/naloxone hydrochloride | 13 | 728 | £550 | -25.0% ▼ |
| Nalmefene | 13 | 364 | £1.1K | +53.3% ▲ |
| Mebendazole | 13 | 342 | £19 | +13.6% ▲ |
| Metformin hydrochloride/sitagliptin | 13 | 784 | £131 | -65.3% ▼ |
| Metronidazole | 13 | 520 | £53 | +96.6% ▲ |
| Etonogestrel | 13 | 13 | £1.1K | -55.0% ▼ |
| Levonorgestrel | 13 | 13 | £1.1K | -65.6% ▼ |
| Tacrolimus | 13 | 750 | £746 | -51.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.